RAC 5.06% $1.69 race oncology ltd

General Comments / Chat, page-7131

  1. 2,941 Posts.
    lightbulb Created with Sketch. 3564
    FWIW I would vote no against any offer presented prior to clinical validation.

    The anecdotal evidence is far too strong and we all just chipped in $30m to further our clinical programs.

    But, you can see it here in this thread. Holders are deflated, and in my view, they're about to be swindled by the big end of town.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.